As tau progression correlates with neurodegeneration and cognitive deficits [3, 47], there is expanding interest in how tau seeding and propagation throughout the human brain correlates with the clinicopathology of different tauopathies and if it contributes to variability in clinical symptom presentation. This evidence concerns the gene MAPT and tauopathy.